Mice with a human touch

Nature Biotechnology

Volumn 25, Issue 10, 2007, Pages 1075-1077

  Scott, Christopher Thomas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CETUXIMAB; DENOSUMAB; INFLIXIMAB; MONOCLONAL ANTIBODY; OKT 3; PALIVIZUMAB; PANITUMUMAB; RITUXIMAB; TGN 1412; TRASTUZUMAB; UNCLASSIFIED DRUG; VECTIBIX;

ANTIBODY PRODUCTION; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATORIAL CHEMISTRY; CROHN DISEASE; DRUG INDICATION; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENETICS; IMMUNOPHARMACOLOGY; IMMUNOTHERAPY; IMMUNOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOTECHNOLOGY; DRUG INDUSTRY; HUMANS; IMMUNOGLOBULINS; MICE; MICE, TRANSGENIC; PATENTS AS TOPIC; SPECIES SPECIFICITY;

MUS;

EID: 35148866620     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1007-1075     Document Type: Short Survey

References (10)

1. Baker, M. Nat. Biotechnol. 23, 1065-1072 (2005).
2. Scott, C.T. Nat. Biotechnol. 23, 1037-1041 (2005).
3. Eisenstein, M. Nat Methods 1, 753-762 (2004).
4. King, J. Nat. Biotechnol. 24, 119 (2006).
5. Hamers-Casterman, C. et al. Nature 363, 446-448 (1993).
6. Coughlin, M. et al. Virology 361, 93-102 (2007).
7. Viau, M. et al. Mol. Immunol. 44, 2124-2134 (2007).
8. Saadeh, C.E. & Lee, H.S. Ann. Pharmacother. 41, 606-613 (2007).
9. Van Cutsem et al., J. Clin. Oncol. 25, 1658-1664 (2007).
10. Graven, U. et al. Br. J. Cancer 94, 1293-1299 (2006).